236 related articles for article (PubMed ID: 26870935)
1. Antifibrotic Therapies: Where Are We Now?
Yoon YJ; Friedman SL; Lee YA
Semin Liver Dis; 2016 Feb; 36(1):87-98. PubMed ID: 26870935
[TBL] [Abstract][Full Text] [Related]
2. An update on the recent advances in antifibrotic therapy.
Tacke F; Weiskirchen R
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1143-1152. PubMed ID: 30261763
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
[TBL] [Abstract][Full Text] [Related]
4. Progress in promising anti-fibrotic therapies.
Santoro R; Mangia A
Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1145-1152. PubMed ID: 31692390
[No Abstract] [Full Text] [Related]
5. Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis.
Wree A; Mehal WZ; Feldstein AE
Semin Liver Dis; 2016 Feb; 36(1):27-36. PubMed ID: 26870930
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs.
Nishikawa K; Osawa Y; Kimura K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308992
[TBL] [Abstract][Full Text] [Related]
7. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
Popov Y; Schuppan D
Hepatology; 2009 Oct; 50(4):1294-306. PubMed ID: 19711424
[TBL] [Abstract][Full Text] [Related]
8. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.
Hauff P; Gottwald U; Ocker M
Expert Opin Investig Drugs; 2015 Mar; 24(3):309-27. PubMed ID: 25547844
[TBL] [Abstract][Full Text] [Related]
9. Hepatic fibrosis--role of hepatic stellate cell activation.
Safadi R; Friedman SL
MedGenMed; 2002 Jul; 4(3):27. PubMed ID: 12466770
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis: Common mechanisms and antifibrotic therapies.
Schuppan D
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S51-9. PubMed ID: 26189980
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrosis: Concept to treatment.
Trautwein C; Friedman SL; Schuppan D; Pinzani M
J Hepatol; 2015 Apr; 62(1 Suppl):S15-24. PubMed ID: 25920084
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Friedman SL
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
[TBL] [Abstract][Full Text] [Related]
13. Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.
Torok NJ; Dranoff JA; Schuppan D; Friedman SL
Hepatology; 2015 Aug; 62(2):627-34. PubMed ID: 25626988
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target.
Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Yang Y; Li J
Biochimie; 2015 Jan; 108():1-7. PubMed ID: 25447141
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapies for liver fibrosis.
Fowell AJ; Iredale JP
Dig Dis; 2006; 24(1-2):174-83. PubMed ID: 16699275
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fibrosis: molecular mechanisms and drug targets.
Lotersztajn S; Julien B; Teixeira-Clerc F; Grenard P; Mallat A
Annu Rev Pharmacol Toxicol; 2005; 45():605-28. PubMed ID: 15471534
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Fibrosis: Emerging Therapies.
Friedman SL
Dig Dis; 2015; 33(4):504-7. PubMed ID: 26159266
[TBL] [Abstract][Full Text] [Related]
18. Liver Fibrosis: From Pathogenesis to Novel Therapies.
Weiskirchen R; Tacke F
Dig Dis; 2016; 34(4):410-22. PubMed ID: 27170396
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic therapy in chronic liver disease.
Rockey DC
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):95-107. PubMed ID: 15704042
[TBL] [Abstract][Full Text] [Related]
20. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
